Is fibromyalgia-related oxidative stress implicated in the decline of physical and mental health status?

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.79, 2013, Pages

  La Rubia, Mercedes ^a   Rus, Alma ^a   Molina, Francisco ^a   del Moral, Maria Luisa ^a  

^a UNIVERSITY OF JAÉN   (Spain)

Author keywords

Catalase.; Fibromyalgia; Glutathione peroxidase; Lipid peroxidation; Oxidative stress; Superoxide dismutase

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALBUMIN; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; LIPID PEROXIDATION; MALE; MENTAL COMPONENT SUMMARY; MIDDLE AGED; MUSCULOSKELETAL PAIN; OXIDATIVE STRESS; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSICAL COMPONENT SUMMARY; PRIORITY JOURNAL; SCORING SYSTEM; SHORT FORM 12; VISUAL ANALOG SCALE;

EID: 84892470408     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. WOLFE F, ROSS K, ANDERSON J, RUSSELL IJ, HEBERT L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
2. CARMONA L, BALLINA J, GABRIEL R, LAFFON A; EPISER Study Group: The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 2001; 60: 1040-5.
3. SARZI-PUTTINI P, ATZENI F, Di FRANCO M et al.: Dysfunctional syndromes and fibromyalgia: a 2012 critical digest. Clin Exp Rheumatol 2012; 30: 143-51.
4. GUIGNARD S: Fibromyalgia: a daring new look. Clin Exp Rheumatol 2013; 31 (Suppl. 79): S3-5.
5. EISINGER J, ZAKARIAN H, POULY E, PLANTAMURA A, AYAVOU T: Protein peroxidation, magnesium deficiency and fibromyalgia. Magnes Res 1996; 9: 313-6.
6. BAGIS S, TAMER L, SAHIN G, BILGIN R, GULER H, ERCAN B, ERDOGAN C: Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?. Rheumatol Int 2005; 25: 188-90.
7. OZGOCMEN S, OZYURT H, SOGUT S, AKYOL O, ARDICOGLU O, YIDIZHAN H (a): Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 2006; 26: 598-603.
8. OZGOCMEN S, OZYURT H, SOGUT S, AKYOL O (b): Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int 2006; 26: 585-97.
9. ALTINDAG O, CELIK H: Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 2006; 11: 131-5.
10. AKKUS S, NAZIROGLU M, ERIS S, YALMAN K, YILMAZ N, YENER M: Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochem Funct 2009; 27: 181-5.
11. SENDUR OF, TURAN Y, TASTABAN E, YENISEY C, SERTER M: Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int 2009; 29: 629-33.
12. Al-GEBORI AM, TARIK M, RAJAB A, Al-OSAMI MH, TURKI KM: Levels of magnesium, zinc, calcium and copper in serum of patients with fibromyalgia syndrome. The Iraqi Postgraduate Medical Journal 2011; 10: 180-3.
13. BAZZICHI L, CIREGIA F, GIUSTI L et al.: Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin Appl 2009; 3: 1296-304.
14. FULLE S, MECOCCI P, FANó G et al.: Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radic Biol Med 2000; 29: 1252-9.
15. AKYOL O, ISCI N, TEMEL I et al.: The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 2001; 68: 311-7.
16. OZGOCMEN S, SOGUT S, ARDICOGLU O, FADILLIOGLU E, PEKKUTUCU I, AKYOL O: Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 2004; 24: 80-3.
17. DRöGE W: Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
18. HORTON AA, FAIRHURST S: Lipid peroxidation and mechanisms of toxicity. Crit Rev Toxicol 1987; 18: 27-79.
19. STADTMAN ER, OLIVER CN: Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 1991; 266: 2005-8.
20. COOKE MS, EVANS MD, HERBERT KE, LUNEC J: Urinary 8-oxo-2'-deoxyguanosinesource, significance and supplements. Free Radic Res 2000; 32: 381-97.
21. GUTTERIDGE JM: Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-28.
22. POWELL SR: The antioxidant properties of zinc. J Nutr 2000; 130: 1447-54.
23. IBI M, MATSUNO K, SHIBA D et al.: Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. J Neurosci 2008; 28: 9486-94.
24. SCHWARTZ ES, KIM HY, WANG J et al.: Persistent pain is dependent on spinal mitochondrial antioxidant levels. J Neurosci 2009; 29: 159-68.
25. KIM HY, CHUNG JM, CHUNG K: Increased production of mitochondrial superoxide in the spinal cord induces pain behaviors in mice: the effect of mitochondrial electron transport complex inhibitors. Neurosci Lett 2008; 447: 87-91.
26. WANG ZQ, PORRECA F, CUZZOCREA S et al.: A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 2004; 309: 869-78.
27. GAO X, KIM HK, CHUNG JM, CHUNG K: Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain. Pain 2007; 131: 262-71.
28. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72.
29. MONTERDE S, SALVATA I, MONTULLA S, FERNáNDEZ-BALLART J: Validación de la versión española del Fibromyalgia Impact Questionnaire. Rev Esp Reumatol 2004; 31: 507-13. [Article in Spanish].
30. VILAGUT G, FERRER M, RAJMIL L et al.: The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit 2005; 19: 135- 50. Spanish.
31. WU MW, ZENG ZL, LI S et al.: Circadian variation of plasma cortisol and whole blood reduced glutathione levels in nasopharyngeal carcinoma patients. Ai Zheng 2008; 27: 237- 42.
32. BOYUM A: Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest Suppl 1968; 97: 7.
33. LEFèVRE G, BELJEAN-LEYMARIE M, BEYERLE F et al.: Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Ann Biol Clin (Paris) 1998; 56: 305-19. [Article in French].
34. ESPINOSA O, JIMÉNEZ-ALMAZáN J, CHAVES FJ et al.: Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension. Free Radic Res 2007; 41: 546-54.
35. WEI H, FRENKEL K: Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: A possible mechanism of antipromotion. Cancer Res 1992; 52: 2298-303.
36. NEBOT C, MOUTET M, HUET P, XU JZ, YADAN JC, CHAUDIERE J: Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 1993; 214: 442-51.
37. MARKWELL MA, HAAS SM, BIEBER LL, TOLBERT NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978 Jun; 87: 206-10.
38. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
39. HEIN G, FRANKE S: Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia? Rheumatology (Oxford) 2002; 41: 1163-7.
40. MAES M, MIHAYLOVA I, KUBERA M, UYTTERHOEVEN M, VRYDAGS N, BOSMANS E: Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/ chronic fatigue syndrome. Neuro Endocrinol Lett 2009; 30: 715-22.
41. BELIA S, PIETRANGELO T, FULLE S et al.: Sodium nitroprusside, a NO donor, modifies Ca21 transport and mechanical properties in frog skeletal muscle. J Muscle Res Cell Motil 1998; 19: 865-76.
42. JACKSON MJ, O'FARRELL S: Free radicals and muscle damage. Br Med Bull 1993; 49: 630-41.
43. HEIN G, FRANKE S: Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia? Rheumatology (Oxford) 2002; 41: 1163-7.
44. EISINGER J, PLANTAMURA A, MARIE PA, AYAVOU T: Selenium and magnesium status in fibromyalgia. Magnes Res 1994; 7: 285-8.
45. CORDERO MD, ALCOCER-GóMEZ E, CANOGARCíA FJ et al.: Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One 2011; 6: e26915.
46. CORDERO MD, CANO-GARCíA FJ, ALCOCERGóMEZ E, De MIGUEL M, SáNCHEZ-ALCáZAR JA: Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q10 effect on clinical improvement. PLoS One 2012; 7: e35677.
47. CASTRO-MARRERO J, CORDERO MD, SáEZFRANCAS N et al.: Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal 2013; 19: 1855-60.
48. NEYAL M, YIMENICIOGLU F, AYDENIZ A et al.: Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg 2013; 115: 736-40.
49. SENDUR OF, TASTABAN E, TURAN Y, ULMAN C: The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia. Rheumatol Int 2008; 28: 1117-21.
50. BONACCORSO S, LIN AH, VERKERK R et al.: Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers. J Affect Disord 1998; 48: 75-82.
51. ORTANCIL O, SANLI A, ERYUKSEL R, BASARAN A, ANKARALI H: Association between serum ferritin level and fibromyalgia syndrome. Eur J Clin Nutr 2010; 64: 308-12.
52. KIM YS, KIM KM, LEE DJ et al.: Women with fibromyalgia have lower levels of calcium, magnesium, iron and manganese in hair mineral analysis. J Korean Med Sci 2011; 26: 1253-7.
53. MADER R, KOTON Y, BUSKILA D, HERER P, ELIAS M: Serum iron and iron stores in non-anemic patients with fibromyalgia. Clin Rheumatol 2012; 31: 595-9.
54. MAES M, MIHAYLOVA I, KUBERA M, UYTTERHOEVEN M, VRYDAGS N, BOSMANS E: Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression. Neuro Endocrinol Lett 2011; 32: 133-40.
55. CLOSE GL, ASHTON T, MCARDLE A, Mac LAREN DP: The emerging role of free radicals in delayed onset muscle soreness and contraction-induced muscle injury. Comp Biochem Physiol A Mol Integr Physiol 2005; 142: 257-66.
56. MUSCOLI C, CUZZOCREA S, RILEY DP et al.: On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol 2003; 140: 445-60.
57. MEEUS M, NIJS J, HERMANS L, GOUBERT D, CALDERS P: The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets? Expert Opin Ther Targets 2013; 17: 1081-9.